Caution: Should we be treating HIV infection early?

Lancet

Volumn 352, Issue 9132, 1998, Pages 982-983

  Levy, Jay A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CYTOKINE; INTERLEUKIN 2; PROTEINASE INHIBITOR;

CELLULAR IMMUNITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; PATIENT COMPLIANCE; PRIORITY JOURNAL; SHORT SURVEY; TIME; VIRUS LOAD; VIRUS REPLICATION;

EID: 0032547526     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)05391-4     Document Type: Note

References (23)

1. 1 Levy JA. HIV and the pathogenesis of AIDS. 2nd edn. Washington, DC: American Society of Microbiology, 1998.
2. 2 Miller KD, Jones E, Yanovski JA, Shankar R, Reuerstein I, Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871-75.
3. 3 Gallet B, Pulik M, Genet P, Chedin P, Hiltgen M. Vascular complications associated with use of HIV protease inhibitors. Lancet 1998; 351: 1958-59.
4. 4 Decks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors. JAMA 1997; 277: 145-53.
5. 5 Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia. Science 1997; 278: 1447-50.
6. 6 Stranford S, Skurnick J, Louria D, et al. HIV-exposed uninfected individuals appear to be protected by a CD8+ cell anti-HIV noncytotoxic response. Submitted.
7. 7 Rowland-Jones SL, McMichael A. Immune responses in HIV-exposed seronegatives: have they repelled the virus? Curr Opin Immunol 1995; 7: 448-55.
8. 8 Levy JA. HIV pathogenesis and long-term survival. AIDS 1993; 7: 1401-10.
9. 9 Shearer GM, Clerici M. Protective immunity against HIV infection: has nature done the experiment for us? Immunol Today 1996; 17: 21-24.
10. 10 Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993; 362: 359-62.
11. 11 Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HIV infection in 1998. JAMA 1998; 280: 78-86.
12. 12 Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995; 332: 201-08.
13. 13 Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998; 279: 2103-06.
14. 14 Angel JB, Kumar A, Parato K, et al. Improvement in cell-mediated function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir. J Infect Dis 1998; 177: 898-904.
15. 15 Montaner JSG, Harris M, Mo T, Harrigan PR. Rebound of plasma HIV viral load following prolonged suppression with combination therapy. AIDS 1998; 12: 1398-99.
16. 16 Tenner-Racz K, Stellbrink HJ, van Lunzen J, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J Clin Invest 1998; 187: 949-59.
17. 17 Levy JA. HIV research: a need to focus on the right target. Lancet 1995; 345: 1619-21.
18. 18 Levy JA. Surrogate markers in AIDS research. Is there truth in numbers? JAMA 1996; 276: 161-62.
19. 19 Dimitrov DS, Willey RL, Sato H, Chang L-J, Blumenthal R, Martin MA. Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 1993; 67: 2182-90.
20. 20 Levy JA, Ramachandran B, Barker E, Guthrie J, Elbeik T. Plasma viral load, CD4+ cell counts, and HIV-1 production by cells. Science 1996; 271: 670-71.
21. 21 Blackbourn DJ, Mackewicz CE, Barker E, et al. Suppression of HIV replication by lymphoid tissue CD8+ cells correlates with the clinical state of HIV-infected individuals. Proc Natl Acad Sci USA 1996; 93: 13125-30.
22. 22 Autran B, Carcelain G, Li TS, et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112-16.
23. 23 Mackall CL, Fleisher TA, Brown MR, et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N Engl J Med 1995; 332: 143-49.